Xu P, Li M, Jiang Q, Yang C, Liu X, Takiff H
Infect Drug Resist. 2024; 17:919-926.
PMID: 38481653
PMC: 10933515.
DOI: 10.2147/IDR.S436563.
Suhairi M, Mohamad M, Isa M, Mohd Yusoff M, Ismail N
BMJ Open. 2024; 14(2):e080144.
PMID: 38413152
PMC: 10900436.
DOI: 10.1136/bmjopen-2023-080144.
Wang Y, Chen H, Zeng X, Liao L, Lu X, Zhang A
BMC Public Health. 2024; 24(1):526.
PMID: 38378516
PMC: 10877832.
DOI: 10.1186/s12889-024-18023-w.
Jeong Y, Park J, Kim H, Min J, Ko Y, Oh J
Front Public Health. 2023; 11:1207284.
PMID: 37719730
PMC: 10502314.
DOI: 10.3389/fpubh.2023.1207284.
Wang C, Yang X, Zhang H, Zhang Y, Tao J, Jiang X
Front Public Health. 2023; 11:1225931.
PMID: 37575123
PMC: 10413982.
DOI: 10.3389/fpubh.2023.1225931.
Using an Artificial Intelligence Approach to Predict the Adverse Effects and Prognosis of Tuberculosis.
Liao K, Liu C, Chen C, Feng J, Shu C, Ma Y
Diagnostics (Basel). 2023; 13(6).
PMID: 36980382
PMC: 10047137.
DOI: 10.3390/diagnostics13061075.
The Dysbiosis Triggered by First-Line Tuberculosis Antibiotics Fails to Reduce Their Bioavailability.
Namasivayam S, Zimmerman M, Oland S, Wang H, Mittereder L, Dartois V
mBio. 2023; 14(2):e0035323.
PMID: 36877010
PMC: 10127996.
DOI: 10.1128/mbio.00353-23.
Association of Xpert MTB/RIF Cycle Threshold Values with Tuberculosis Treatment Outcomes.
Pires M, Pereira G, Barbosa M, Dias N, Secchi C, Hoff J
Lung. 2020; 198(6):985-989.
PMID: 33128653
DOI: 10.1007/s00408-020-00398-3.
Characteristics and predictors for tuberculosis related mortality in Denmark from 2009 through 2014: A retrospective cohort study.
Holden I, Lillebaek T, Andersen P, Wejse C, Johansen I
PLoS One. 2020; 15(6):e0231821.
PMID: 32497102
PMC: 7272085.
DOI: 10.1371/journal.pone.0231821.
Tuberculosis deaths are predictable and preventable: Comprehensive assessment and clinical care is the key.
Bhargava A, Bhargava M
J Clin Tuberc Other Mycobact Dis. 2020; 19:100155.
PMID: 32211519
PMC: 7082610.
DOI: 10.1016/j.jctube.2020.100155.
Trends and risk factors for death and excess all-cause mortality among notified tuberculosis patients in the UK: an analysis of surveillance data.
Pedrazzoli D, Kranzer K, Thomas H, Lalor M
ERJ Open Res. 2019; 5(4).
PMID: 31857993
PMC: 6911924.
DOI: 10.1183/23120541.00125-2019.
Determinants of mortality among patients with drug-resistant tuberculosis in northern Nigeria.
Bajehson M, Musa B, Gidado M, Nsa B, Sani U, Habibu A
PLoS One. 2019; 14(11):e0225165.
PMID: 31743358
PMC: 6863558.
DOI: 10.1371/journal.pone.0225165.
A mortality review of adult inpatients with tuberculosis in Mendi, Papua New Guinea.
Vakadem K, Anota A, Saavu M, Ramoni C, Comrie-Thomson L, Gale M
Public Health Action. 2019; 9(Suppl 1):S62-S67.
PMID: 31579652
PMC: 6735451.
DOI: 10.5588/pha.18.0068.
Tuberculosis mortality and associated factors at King Abdulaziz Medical City Hospital.
Aljadani R, Ahmed A, Al-Jahdali H
BMC Infect Dis. 2019; 19(1):427.
PMID: 31096930
PMC: 6524290.
DOI: 10.1186/s12879-019-4063-7.
Non-response to first-line anti-tuberculosis treatment in Sikkim, India: a risk-factor analysis study.
Singhi L, Sagili K, Sharath B, Bhandari K, Dadul P, Gautam M
Public Health Action. 2019; 8(4):162-168.
PMID: 30775275
PMC: 6361490.
DOI: 10.5588/pha.18.0026.
Treatment outcomes and factors affecting treatment outcomes of new patients with tuberculosis in Busan, South Korea: a retrospective study of a citywide registry, 2014-2015.
Mok J, An D, Kim S, Lee M, Kim C, Son H
BMC Infect Dis. 2018; 18(1):655.
PMID: 30545315
PMC: 6293515.
DOI: 10.1186/s12879-018-3574-y.
Clinical features of octogenarian patients with tuberculosis at a tertiary hospital in South Korea.
Min J, Shin Y, Lee W, Truong T, Kang E, An J
J Int Med Res. 2018; 47(1):271-280.
PMID: 30343587
PMC: 6384473.
DOI: 10.1177/0300060518800597.
Treatment outcomes and factors affecting unsuccessful outcome among new pulmonary smear positive and negative tuberculosis patients in Anqing, China: a retrospective study.
Wen Y, Zhang Z, Li X, Xia D, Ma J, Dong Y
BMC Infect Dis. 2018; 18(1):104.
PMID: 29506480
PMC: 5836329.
DOI: 10.1186/s12879-018-3019-7.
Reduction of HIV-associated excess mortality by antiretroviral treatment among tuberculosis patients in Kenya.
Onyango D, Yuen C, Cain K, Ngari F, Masini E, Borgdorff M
PLoS One. 2017; 12(11):e0188235.
PMID: 29145454
PMC: 5690617.
DOI: 10.1371/journal.pone.0188235.
Magnitude and determinants of adverse treatment outcomes among tuberculosis patients registered under Revised National Tuberculosis Control Program in a Tuberculosis Unit, Wardha, Central India: A record-based cohort study.
Mundra A, Deshmukh P, Dawale A
J Epidemiol Glob Health. 2017; 7(2):111-118.
PMID: 28315657
PMC: 7320429.
DOI: 10.1016/j.jegh.2017.02.002.